The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular and prognostic convergence of HR+/HER2– metastatic breast cancer (MBC) to a TNBC-like profile: Insights from circulating tumor DNA (ctDNA)-based genomic analysis across treatment lines.
 
Lorenzo Foffano
No Relationships to Disclose
 
Carolina Reduzzi
No Relationships to Disclose
 
Andrew Davis
Consulting or Advisory Role - bioTheranostics; Pfizer
 
Emily Podany
No Relationships to Disclose
 
Arielle Medford
Consulting or Advisory Role - AstraZeneca; Edgewood Oncology; Guardant Health; Illumina; Myriad Genetics; Natera; Novartis; Science for America
Speakers' Bureau - Natera
Research Funding - AstraZeneca (Inst)
 
Katherine Clifton
Employment - Zing Health (I)
Stock and Other Ownership Interests - Centene (I); WellCare (I)
Consulting or Advisory Role - bioTheranostics; Pfizer
Research Funding - Biovica (Inst)
 
Marko Velimirovic
Stock and Other Ownership Interests - Abbvie; Amgen
 
Annika Putur
No Relationships to Disclose
 
Letizia Pontolillo
Speakers' Bureau - Daiichi Sankyo/Astra Zeneca
Travel, Accommodations, Expenses - Gilead Sciences; Lilly; Pfizer
 
Shaili Tapiavala
No Relationships to Disclose
 
Elisabetta Molteni
No Relationships to Disclose
 
Eleonora Nicolò
No Relationships to Disclose
 
Brenno Pastò
Travel, Accommodations, Expenses - Lilly
 
William Gradishar
Consulting or Advisory Role - AstraZeneca; Genentech/Roche; Gilead Sciences; merck; Novartis; Pfizer
 
Cynthia Ma
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Daiichi Sankyo/Astra Zeneca; Danatlas; Foundation Medicine; Genzyme; Lilly; Merck; Merck; Novartis; Olaris; Pfizer; Regor Therapeutics Group; Stemline Therapeutics; Stemline Therapeutics; Tersera; Tersera
Research Funding - Pfizer (Inst); Puma Biotechnology (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate: Authorship - served as a co-author on the subject of endocrine therapy for metastatic breast cancer and receive compensation as an author, less than a few hundred dollars a year. It does not affect my patient care or research.
 
Eleni Andreopoulou
No Relationships to Disclose
 
Fabio Puglisi
Honoraria - AstraZeneca; Daiichi Sankyo; Eisai; Exact Sciences; Lilly; Menarini; MSD; Novartis; Pfizer; Pierre Fabre; Roche
Consulting or Advisory Role - Amgen; AstraZeneca/Daiichi Sankyo; Daiichi Sankyo Europe GmbH; Eisai; Gilead Sciences; Italfarmaco; Lilly; Menarini; Novartis; Pfizer; Pierre Fabre; Roche; Seagen; Viatris
Research Funding - AstraZeneca; Eisai; Roche
Travel, Accommodations, Expenses - Amgen; Astrazeneca; Celgene; GlaxoSmithKline; Lilly; MSD; Novartis; Pfizer; Pfizer; Roche
 
Aditya Bardia
Consulting or Advisory Role - Alyssum; Daiichi Sankyo/Astra Zeneca; Genentech; Genentech/Roche (Inst); Gilead Sciences; Gilead Sciences (Inst); Innocrin Pharma (Inst); Lilly; Lilly (Inst); Menarini; Menarini (Inst); Merck; Mersana; Novartis; Novartis (Inst); Pfizer; Pfizer (Inst); Radius Health (Inst); Sanofi
Research Funding - AstraZeneca/Daiichi Sankyo (Inst); Genentech (Inst); Immunomedics (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst); Sanofi (Inst)
 
Lorenzo Gerratana
Consulting or Advisory Role - Abbvie; AstraZeneca; Daiichi Sankyo Europe GmbH; GlaxoSmithKline; Incyte; Lilly; Menarini Group; Merck Sharp & Dohme; Novartis; Pfizer
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Menarini Group; Novartis
 
Massimo Cristofanilli
Consulting or Advisory Role - Daiichi Sankyo; Genentech; Gilead Sciences; Lilly; Menarini; Merck; Mersana; Novartis; Pfizer; Sanofi
Research Funding - AstraZeneca; Genentech; Immunomedics; Merck; Novartis; Pfizer Hellas; Radius Health; Sanofi